Compare Stocks → 4x Better than Bitcoin (From Behind the Markets) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:ABCNOTCMKTS:ATTBF Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABCNVIVO CannabisC$1.32+5.6%C$1.32C$0.80▼C$4.06C$256.62MN/A1.51 million shs310,601 shsATTBFAbattis Bioceuticals$0.00$0.00▼$0.00N/AN/A11,650 shs100,000 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABCNVIVO Cannabis0.00%0.00%0.00%0.00%0.00%ATTBFAbattis Bioceuticals0.00%0.00%0.00%0.00%0.00%Bombshell 2024 election documentary (Ad)2024: America’s Last Election New documentary reveals why this could be America’s Last Election… and how the elites’ plan threatens to reset the entire U.S. economy, along with your 401(k), bank, and stock portfolio.All the facts are here.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABCNVIVO CannabisN/AN/AN/AN/AN/AN/AN/AN/AATTBFAbattis BioceuticalsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABCNVIVO CannabisN/AN/AN/AN/AATTBFAbattis BioceuticalsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABCNVIVO CannabisN/AN/AN/AN/AN/AN/AATTBFAbattis BioceuticalsN/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABCNVIVO CannabisN/AN/A0.00∞N/AN/AN/AN/AN/AATTBFAbattis BioceuticalsN/A-$0.16N/AN/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABCNVIVO CannabisN/AN/AN/AN/AN/AATTBFAbattis BioceuticalsN/AN/AN/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipABCNVIVO CannabisN/AATTBFAbattis Bioceuticals32.45%Insider OwnershipCompanyInsider OwnershipABCNVIVO CannabisN/AATTBFAbattis BioceuticalsN/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableABCNVIVO CannabisN/A194.41 millionN/ANot OptionableATTBFAbattis BioceuticalsN/AN/AN/ANot OptionableATTBF, ABCN, ABZA, and AHZ HeadlinesSourceHeadlineAbattis Bioceuticals Corp ATTBFmorningstar.com - November 11 at 8:24 AMIllumina Aktiefinanzen100.de - June 28 at 8:57 PMHow a Jungle Prison Became a Famous Spaceportsmithsonianmag.com - June 24 at 12:03 AMIsotretinoin Price of 93 Brandsmedindia.net - May 9 at 12:56 PMIvermectin Price of 102 Brandsmedindia.net - April 20 at 12:36 PMAbattis Bioceuticals Corp ATTBF Sustainabilitymorningstar.com - September 9 at 10:20 PMWhen Will New Jersey's Marijuana Sales Begin? What's Next After Yet Another Delay?benzinga.com - March 27 at 6:36 PMCannabis Payments Co Launches Women In Finance & Technology Scholarshipbenzinga.com - March 26 at 8:52 PMCharlotte's Web Q4 Revenue Up 5% QoQ, Adjusted EBITDA Loss Improves By $5Mbenzinga.com - March 25 at 11:58 PMFederal Marijuana Cases Drop Again In 2021 As More States Legalizebenzinga.com - March 20 at 10:08 PMSchwazze Common Shares Will Trade On NEO Exchange Under Symbol 'SHWZ' In Late Marchbenzinga.com - March 20 at 10:08 PMMDXclusive Launches Lab-Tested Topical And Sublingual CBD Productsbenzinga.com - March 9 at 9:22 PMThe Perfect CBD To THC Ratio? New Study Says 1 To 1 Is The Best Ratio For Therapeutic Effectsbenzinga.com - March 6 at 7:27 PMMost D.C. Workers To Avoid Pre-Employment Marijuana Testing Under New Billbenzinga.com - March 5 at 10:25 PMBDSA Report: Global Cannabis Sales Will Jump 22% In 2022, Grow To $61B By 2026benzinga.com - March 3 at 8:58 PMTrulieve Files Resale Registration With SEC For Subordinate Voting Shares Of 2021 Acquisitionsbenzinga.com - January 26 at 12:56 AMLatest Issue Of Psychedelics Mag DoubleBlind Plays With The Tension Between Old And Newbenzinga.com - December 22 at 6:09 PMAbattis Bioceuticals Dividend Per Share (TTM)ycharts.com - December 18 at 12:59 AMAbattis Bioceuticals EPS Diluted (5 Year Growth)ycharts.com - December 18 at 12:59 AMMicah Tapman Of BDSA Lays Out Cannabis Data In The Northeastbenzinga.com - October 18 at 7:08 PMApple's Cannabis iPhone App Is Benefiting Businesses And Consumers, Where's Google Play Store?benzinga.com - September 3 at 9:10 PMPanama Is Close To Legalizing Medicinal Cannabisbenzinga.com - August 31 at 6:25 PMEXCLUSIVE: Healthcare Attorney Brian Rath Discusses Medical Marijuana In Nursing Homes & Assisted Living, Legal? It's Complicatedbenzinga.com - August 18 at 3:50 AMNew MarketBeat Followers Over TimeCompany DescriptionsVIVO CannabisCVE:ABCNABcann Global Corporation manufactures and distributes medical cannabis. The company is headquartered in Napanee, Canada.Abattis BioceuticalsOTCMKTS:ATTBFAbattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.